Telephone: Fax: Post Code:710010 Address:Li Jing Jia Yuan, Wei Qu Xi Jie, Chang'an District,Xi'an,China
Tocilizumab 375823-41-9
Introduction of Tocilizumab:
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. Tocilizumab was jointly developed by Osaka University and Chugai, and was licensed in 2003 by Hoffmann-La Roche.
Function of Tocilizumab:
It is an immunosuppressive drug used to treat rheumatoid arthritis and systemic juvenile idiopathic arthritis.
HEALTH BIOCHEM TECHNOLOGY .,LTD 陕ICP备2021013970号-1